TY - JOUR
T1 - Genome-wide association study of peripheral arterial disease in a Japanese population
AU - Matsukura, Mitsuru
AU - Ozaki, Kouichi
AU - Takahashi, Atsushi
AU - Onouchi, Yoshihiro
AU - Morizono, Takashi
AU - Komai, Hiroyoshi
AU - Shigematsu, Hiroshi
AU - Kudo, Toshifumi
AU - Inoue, Yoshinori
AU - Kimura, Hideo
AU - Hosaka, Akihiro
AU - Shigematsu, Kunihiro
AU - Miyata, Teturo
AU - Watanabe, Toshiaki
AU - Tsunoda, Tatsuhiko
AU - Kubo, Michiaki
AU - Tanaka, Toshihiro
N1 - Publisher Copyright:
© 2015 Matsukura et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2015/10/21
Y1 - 2015/10/21
N2 - Characteristics of peripheral arterial disease (PAD) are the occlusion or stenosis of multiple vessel sites caused mainly by atherosclerosis and chronic lower limb ischemia. To identify PAD susceptible loci, we conducted a genome-wide association study (GWAS) with 785 cases and 3,383 controls in a Japanese population using 431,666 single nucleotide polymorphisms (SNP). After staged analyses including a total of 3,164 cases and 20,134 controls, we identified 3 novel PAD susceptibility loci at IPO5/RAP2A, EDNRA and HDAC9 with genome wide significance (combined P = 6.8 x 10-14, 5.3 x 10-9 and 8.8 x 10-8, respectively). Fine-mapping at the IPO5/RAP2A locus revealed that rs9584669 conferred risk of PAD. Luciferase assay showed that the risk allele at this locus reduced expression levels of IPO5. To our knowledge, these are the first genetic risk factors for PAD.
AB - Characteristics of peripheral arterial disease (PAD) are the occlusion or stenosis of multiple vessel sites caused mainly by atherosclerosis and chronic lower limb ischemia. To identify PAD susceptible loci, we conducted a genome-wide association study (GWAS) with 785 cases and 3,383 controls in a Japanese population using 431,666 single nucleotide polymorphisms (SNP). After staged analyses including a total of 3,164 cases and 20,134 controls, we identified 3 novel PAD susceptibility loci at IPO5/RAP2A, EDNRA and HDAC9 with genome wide significance (combined P = 6.8 x 10-14, 5.3 x 10-9 and 8.8 x 10-8, respectively). Fine-mapping at the IPO5/RAP2A locus revealed that rs9584669 conferred risk of PAD. Luciferase assay showed that the risk allele at this locus reduced expression levels of IPO5. To our knowledge, these are the first genetic risk factors for PAD.
UR - http://www.scopus.com/inward/record.url?scp=84949213761&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949213761&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0139262
DO - 10.1371/journal.pone.0139262
M3 - Article
C2 - 26488411
AN - SCOPUS:84949213761
SN - 1932-6203
VL - 10
JO - PloS one
JF - PloS one
IS - 10
M1 - e0139262
ER -